Aveanna Healthcare (NASDAQ:AVAH) Insider Sells 11,839 Shares

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) insider Patrick Cunningham sold 11,839 shares of the stock in a transaction that occurred on Tuesday, December 30th. The stock was sold at an average price of $8.36, for a total value of $98,974.04. Following the completion of the transaction, the insider directly owned 317,530 shares in the company, valued at approximately $2,654,550.80. This trade represents a 3.59% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Aveanna Healthcare Stock Down 1.1%

NASDAQ AVAH traded down $0.09 on Friday, reaching $8.08. 2,526,966 shares of the stock traded hands, compared to its average volume of 1,076,101. Aveanna Healthcare Holdings Inc. has a 12 month low of $3.67 and a 12 month high of $10.32. The company has a market cap of $1.69 billion, a price-to-earnings ratio of 22.44 and a beta of 2.06. The company has a fifty day moving average price of $8.92 and a 200-day moving average price of $7.49. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings results on Monday, May 22nd. The company reported $0.04 earnings per share (EPS) for the quarter. The business had revenue of $450.53 million for the quarter. Aveanna Healthcare had a negative return on equity of 143.55% and a net margin of 3.29%. As a group, research analysts forecast that Aveanna Healthcare Holdings Inc. will post -0.06 EPS for the current fiscal year.

Institutional Investors Weigh In On Aveanna Healthcare

Several institutional investors have recently bought and sold shares of AVAH. Dynamic Technology Lab Private Ltd increased its position in shares of Aveanna Healthcare by 8.9% during the third quarter. Dynamic Technology Lab Private Ltd now owns 14,149 shares of the company’s stock worth $126,000 after purchasing an additional 1,151 shares in the last quarter. Barclays PLC boosted its position in shares of Aveanna Healthcare by 0.8% in the 3rd quarter. Barclays PLC now owns 179,359 shares of the company’s stock worth $1,591,000 after purchasing an additional 1,366 shares in the last quarter. Franklin Resources Inc. boosted its position in shares of Aveanna Healthcare by 4.5% in the 3rd quarter. Franklin Resources Inc. now owns 35,630 shares of the company’s stock worth $316,000 after purchasing an additional 1,528 shares in the last quarter. Olympiad Research LP grew its stake in Aveanna Healthcare by 7.5% during the 3rd quarter. Olympiad Research LP now owns 31,621 shares of the company’s stock worth $280,000 after buying an additional 2,200 shares during the last quarter. Finally, Rhumbline Advisers increased its position in Aveanna Healthcare by 4.0% during the 1st quarter. Rhumbline Advisers now owns 75,581 shares of the company’s stock valued at $410,000 after buying an additional 2,918 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

AVAH has been the subject of several recent research reports. Weiss Ratings restated a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Monday. UBS Group lifted their price objective on shares of Aveanna Healthcare from $9.00 to $9.50 and gave the company a “neutral” rating in a report on Friday, November 7th. Zacks Research downgraded shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 20th. Royal Bank Of Canada upped their target price on Aveanna Healthcare from $8.00 to $10.00 and gave the stock a “sector perform” rating in a report on Friday, October 24th. Finally, Raymond James Financial reaffirmed an “outperform” rating and set a $13.00 target price on shares of Aveanna Healthcare in a research report on Friday, December 5th. Five equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat, Aveanna Healthcare presently has an average rating of “Hold” and a consensus price target of $10.69.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.